BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17606134)

  • 1. Balloon control of the saphenofemoral junction during foam sclerotherapy: proposed innovation.
    Bidwai A; Beresford T; Dialynas M; Prionidis J; Panayiotopoulos Y; Browne TF
    J Vasc Surg; 2007 Jul; 46(1):145-7. PubMed ID: 17606134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regarding "Balloon control of the saphenofemoral junction during foam sclerotherapy: proposed innovation".
    Morrison N
    J Vasc Surg; 2008 Mar; 47(3):693. PubMed ID: 18295125
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of techniques to reduce sclerosant foam migration during ultrasound-guided sclerotherapy of the great saphenous vein.
    Hill D; Hamilton R; Fung T
    J Vasc Surg; 2008 Oct; 48(4):934-9. PubMed ID: 18692353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower pain and faster treatment with mechanico-chemical endovenous ablation using ClariVein®.
    Vun SV; Rashid ST; Blest NC; Spark JI
    Phlebology; 2015 Dec; 30(10):688-92. PubMed ID: 25300311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saphenofemoral incompetence treated by ultrasound-guided sclerotherapy.
    Kanter A; Thibault P
    Dermatol Surg; 1996 Jul; 22(7):648-52. PubMed ID: 8680788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking the saphenofemoral junction during ultrasound-guided foam sclerotherapy-- assessment of a presumed safety-measure procedure.
    Ceulen RP; Jagtman EA; Sommer A; Teule GJ; Schurink GW; Kemerink GJ
    Eur J Vasc Endovasc Surg; 2010 Dec; 40(6):772-6. PubMed ID: 20926321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foam sclerotherapy: techniques and uses.
    Bunke N; Brown K; Bergan J
    Perspect Vasc Surg Endovasc Ther; 2009 Jun; 21(2):91-3. PubMed ID: 19767405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
    Rabe E; Otto J; Schliephake D; Pannier F
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time color duplex scanning after sclerotherapy of the greater saphenous vein.
    Bishop CC; Fronek HS; Fronek A; Dilley RB; Bernstein EF
    J Vasc Surg; 1991 Oct; 14(4):505-8; discussion 508-10. PubMed ID: 1920648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late follow-up of saphenofemoral junction ligation combined with ultrasound-guided foam sclerotherapy in patients with venous ulcers.
    Figueiredo M; de Araujo SP; Figueiredo MF
    Ann Vasc Surg; 2012 Oct; 26(7):977-81. PubMed ID: 22944569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter-directed foam sclerotherapy of axial saphenous reflux: early results.
    Kölbel T; Hinchliffe RJ; Lindblad B
    Phlebology; 2007; 22(5):219-22. PubMed ID: 18269073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-guided sclerotherapy of the great saphenous vein with 1% vs. 3% polidocanol foam: a multicentre double-blind randomised trial with 3-year follow-up.
    Blaise S; Bosson JL; Diamand JM
    Eur J Vasc Endovasc Surg; 2010 Jun; 39(6):779-86. PubMed ID: 20206556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of Ultrasound-Guided Foam Sclerotherapy of the Great Saphenous Vein With New Parameters of the Technique.
    Baeshko A; Shestak N; Korytko S
    Vasc Endovascular Surg; 2016 Nov; 50(8):528-533. PubMed ID: 27837181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins.
    Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
    Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):343-8. PubMed ID: 18922712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foam sclerotherapy of the great saphenous vein in association with pre-terminal saphenous junction ligation/division as an office-based procedure: 12-Month results.
    Leo M; Stefano R; Raffaele AI
    Phlebology; 2018 Jun; 33(5):321-329. PubMed ID: 28440727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of duplex-guided foam sclerotherapy and duplex-guided liquid sclerotherapy for the treatment of superficial venous insufficiency.
    Yamaki T; Nozaki M; Iwasaka S
    Dermatol Surg; 2004 May; 30(5):718-22; discussion 722. PubMed ID: 15099313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ultrasonography during sclerotherapy].
    Schadeck M; Allaert F
    Phlebologie; 1991; 44(1):111-29; discussion 130. PubMed ID: 1946633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infusion of foam sclerosants results in a distance-dependent procoagulant activity, haemoconcentration and elevation of D-dimer levels.
    Connor DE; Joseph JE; Exner T; Ma DD; Parsi K
    Phlebology; 2014 Dec; 29(10):677-87. PubMed ID: 24002013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous disorders: treatment with sclerosant foam.
    Bergan J; Pascarella L; Mekenas L
    J Cardiovasc Surg (Torino); 2006 Feb; 47(1):9-18. PubMed ID: 16434941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: immediate results.
    Kakkos SK; Bountouroglou DG; Azzam M; Kalodiki E; Daskalopoulos M; Geroulakos G
    J Endovasc Ther; 2006 Jun; 13(3):357-64. PubMed ID: 16784324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.